CLINICAL_TRIALS
ClinicalTrials.gov record update
Utility of ctDNA In Predicting Whether Giving Adjuvant Chemotherapy In Patients With Stage IB-IIA Resected Non-small Cell Lung Cancer: A Prospective Cohort Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05167604
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:22.243982+00:00
- Published At
- 2021-12-22T00:00:00+00:00
- Record Updated At
- 2021-12-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Carcinoma, Non-Small-Cell Lung", "Next-Generation Sequencing", "Chemotherapy, Adjuvant", "Neoplasm, Residual", "Circulating Tumor DNA"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-12-22"- protocolSection.identificationModule.nctId
"NCT05167604"- protocolSection.identificationModule.officialTitle
"Utility of ctDNA In Predicting Whether Giving Adjuvant Chemotherapy In Patients With Stage IB-IIA Resected Non-small Cell Lung Cancer: A Prospective Cohort Study"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.